Keywords: gilead, files, hep, drug, adefovir, eu/usa, sciences

Gilead files hep B drug adefovir in EU/USA

Article | 01 April 2002

Print This

Gilead Sciences has submitted its chronic hepatitis B treatment,adefovir dipivoxil 10mg, to the European Medicines Evaluation Agency, just a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in